Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to determine the effect of mepolizumab on exacerbation rates in subjects with severe uncontrolled refractory asthma
mepolizumab
MEA112997
NCT01000506
Asthma
Phase 2
 
November 2015

Powered by ideaPoint, Inc.